Abstract:Given that TLRs and sphingosine-1-phosphate (S1P) are key players in inflammation, we explored the potential interplay between TLRs and S1P in the adhesion/inflammatory pathways in primary human endothelial cells. As determined by Western blot and flow cytometry, cells treated with LPS (a TLR4 ligand) and S1P showed significantly enhanced expression of adhesion molecules such as ICAM-1 and E-selectin compared with the effect of either ligand alone. Cell-type differences on E-selectin upregulation were observed. In contrast, no cooperation effect on ICAM-1 or E-selectin was observed with a TLR2/TLR1 ligand. Consistent with an increase in adhesion molecule expression, endothelial cell treatment with LPS plus S1P significantly enhanced adhesion of PBMCs under shear stress conditions compared with the effect of either ligand alone and exhibited comparable levels of cell adhesion strength as those after TNF-a treatment. Moreover, LPS and S1P cooperated to increase the expression of proinflammatory molecules such as IL-6, cyclooxygenase-2, and prostacyclin, as determined by ELISA and Western blot. The analysis of signaling pathways revealed the synergistic phosphorylation of ERK upon LPS plus S1P treatment of HUVEC and human aortic endothelial cells and cell-type differences on p38 and NF-kB activation. Moreover, pharmacological and small interfering RNA experiments disclosed the involvement of S1P 1/3 and NF-kB in the cooperation effect and that cell origin determines the S1P receptors and signaling routes involved. Sphingosine kinase activity induction upon LPS plus S1P treatment suggests S1P– Sphingosine kinase axis involvement. In summary, LPS and S1P cooperate to increase proinflammatory molecules in endothelial cells and, in turn, to augment leukocyte adhesion, thus exacerbating S1P-mediated proadhesive/proinflammatory properties. S phingosine-1-phosphate (S1P) is a bioactive lipid mediator that mediates a wide spectrum of cell functions in both intracellular and extracellular compartments, which includes proliferation, migration, differentiation, angiogenesis, and lymphocyte trafficking (1–3). Many of the actions of S1P are mediated by the activation of receptors, initially known as endo-thelial differentiation genes and now designated as S1P 1–5 , which are high-affinity receptors coupled to G proteins (a io , a q , or a 12/13) that trigger the activation of multiple signals leading to specific cell responses (4). In addition, S1P can play an important role as a second messenger during inflammation (2). Accumulating evidence suggests an important role of S1P in the regulation of the immune system and the vascular system (2, 5). The S1P–S1P-receptor signaling axis has been implicated in a variety of pathophysiological conditions and diseases such …

Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling.

Sphingosine 1-phosphate and inflammation.

Point-Counterpoint of Sphingosine 1-Phosphate Metabolism

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

How do sphingosine-1-phosphate affect immune cells to resolve inflammation?

Sphingosine‐1‐phosphate receptors and innate immunity

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

S1P/S1PR signaling pathway advancements in autoimmune diseases

Molecular basis of Spns2-facilitated sphingosine-1-phosphate transport

Sphingosine-1-phosphate: a Potential Therapeutic Target for Rheumatoid Arthritis

Deciphering the role of sphingosine 1‐phosphate in central nervous system myelination and repair

Sphingosine 1-phosphate and its regulatory role in vascular endothelial cells

Modulation of protein kinase C and diverse cell functions by sphingosine--a pharmacologically interesting compound linking sphingolipids and signal transduction

Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease.

Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases

The SphKs/S1P/S1PR1 Axis in Immunity and Cancer: More Ore to Be Mined

Sphingosine 1-Phosphate Receptor-3 Enhances Pro-Inflammatory Activity in Human Monocytes (P1384)

Sphingosine-1-phosphate and obesity-induced inflammation

Sphingosine 1-phosphate receptor-3 enhances pro-inflammatory activity in human monocytes

Leukocyte Adhesion in Endothelial Cells Induce Inflammatory Molecules and Sphingosine-1-Phosphate Cooperate To Lipopolysaccharide

The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases